Modification of prostacyclin-stimulatory activity in sera by glucose, insulin, low density lipoprotein, linoleic acid and linoleic acid hydroperoxide.

[1]  H. Nawata,et al.  Abnormality in prostacyclin-stimulatory activity in sera from diabetics. , 1989, Metabolism: clinical and experimental.

[2]  T. Inoguchi,et al.  Glucose Inhibits Prostacyclin Production by Cultured Aortic Endothelial Cells , 1988, Thrombosis and Haemostasis.

[3]  A. A. Spector,et al.  Effect of human plasma lipoproteins on prostacyclin production by cultured endothelial cells. , 1985, Journal of lipid research.

[4]  J. Albers,et al.  Metabolism of Low Density Lipoprotein by Bovine Endothelial Cells as a Function of Cell Density , 1984, Arteriosclerosis.

[5]  P. Edwards,et al.  LDL, scavenger, and beta-VLDL receptors on aortic endothelial cells. , 1984, Arteriosclerosis.

[6]  V. V. van Hinsbergh,et al.  Low Density Lipoprotein Metabolism by Endothelial Cells from Human Umbilical Cord Arteries and Veins , 1983, Arteriosclerosis.

[7]  D. Mikhailidis,et al.  Simulating the Diabetic Environment Modifies In Vitro Prostacyclin Synthesis , 1983, Diabetes.

[8]  R. Larson,et al.  Interaction of Insulin and Prostacyclin Production in the Rat , 1982, Diabetes.

[9]  J. White,et al.  Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. , 1980, The Journal of laboratory and clinical medicine.

[10]  M. Subbiah,et al.  Altered synthesis of prostaglandins in platelet and aorta from spontaneously diabetic Wistar rats. , 1980, Biochemical medicine.

[11]  C. Dollery,et al.  CIRCULATING PROSTACYCLIN MAY BE REDUCED IN DIABETES , 1979, The Lancet.

[12]  M. Mitchell,et al.  PROSTACYCLIN AND THROMBOXANE METABOLITES IN DIABETES , 1979, The Lancet.

[13]  R. Egan,et al.  Peroxidase-dependent deactivation of prostacyclin synthetase. , 1979, The Journal of biological chemistry.

[14]  H. Sinzinger,et al.  Coexistence of deficiency in alpha1 antitrypsin and in growth hormone. , 1979 .

[15]  M. Schydlower,et al.  Coexistence of deficiency in alpha1 antitrypsin and in growth hormone. , 1979, The New England journal of medicine.

[16]  J. Elder,et al.  VASCULAR PROSTACYCLIN MAY BE REDUCED IN DIABETES IN MAN , 1979, The Lancet.

[17]  D. Gospodarowicz,et al.  Effect of contact inhibition on the regulation of cholesterol metabolism in cultured vascular endothelial cells. , 1979, The Journal of biological chemistry.

[18]  K. Yagi,et al.  Reaction of linoleic acid hydroperoxide with thiobarbituric acid. , 1978, Journal of lipid research.

[19]  H. Harrison,et al.  Decreased vascular prostacyclin in experimental diabetes. , 1978, Life sciences.

[20]  J. Vane,et al.  Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. , 1978, British medical bulletin.

[21]  J. Salmon,et al.  Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes. , 1978, Biochimica et biophysica acta.

[22]  J. Pearson,et al.  Localisation and stimulation of prostacyclin production in vascular cells , 1978, Nature.

[23]  C. Stiles,et al.  Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Vane,et al.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation , 1976, Nature.

[25]  B. Jaffe,et al.  Radioimmunoassay measurement of prostaglandins E, A, and F in human plasma. , 1973, The Journal of clinical investigation.

[26]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[27]  H. Nawata,et al.  Reduced stimulatory activity on prostacyclin production by cultured endothelial cells in serum from aged and diabetic patients. , 1989, Atherosclerosis.

[28]  T. Inoguchi,et al.  Stimulatory activity on prostacyclin production decreases in sera from streptozotocin-induced diabetic rats. , 1987, Diabetes research and clinical practice.

[29]  T. Inoguchi,et al.  Reduced serum-stimulatory activity on prostacyclin production by cultured aortic endothelial cells in diabetes mellitus. , 1986, Haemostasis.

[30]  F. Umeda,et al.  Decreased prostacyclin production and platelet abnormalities in diabetes mellitus. , 1985 .

[31]  A. Szczeklik,et al.  Low density lipoproteins (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries. , 1980, Artery.